Wall Street Associates’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $323K | Sell |
19,100
-125,000
| -87% | -$2.11M | 0.21% | 165 |
|
2016
Q3 | $2.37M | Buy |
144,100
+19,100
| +15% | +$313K | 0.81% | 50 |
|
2016
Q2 | $1.89M | Hold |
125,000
| – | – | 0.76% | 48 |
|
2016
Q1 | $1.81M | Hold |
125,000
| – | – | 0.75% | 50 |
|
2015
Q4 | $3.54M | Sell |
125,000
-100,000
| -44% | -$2.83M | 1% | 13 |
|
2015
Q3 | $3.77M | Hold |
225,000
| – | – | 0.72% | 43 |
|
2015
Q2 | $5.9M | Hold |
225,000
| – | – | 0.56% | 65 |
|
2015
Q1 | $3.94M | Hold |
225,000
| – | – | 0.37% | 94 |
|
2014
Q4 | $3.91M | Hold |
225,000
| – | – | 0.37% | 92 |
|
2014
Q3 | $4.19M | Hold |
225,000
| – | – | 0.43% | 87 |
|
2014
Q2 | $4.11M | Buy |
+225,000
| New | +$4.11M | 0.35% | 105 |
|